PCV104 - BETA-BLOCKERS, ANGIOTENSIN II, AND ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN PATIENTS WITH HEART FAILURE. DIFFERENCES IN PRESCRIPTION BY GENDER, SOCIOECONOMIC STATUS AND COMORBIDITY AFTER A FIRST HOSPITALIZATION FOR HEART FAILURE
| Autor: | M. Mateos, M. Robledo, M. Ogueta, Antxon Apiñaniz, N. Jaio, Felipe Aizpuru, M. Armendariz, N. Parraza, R. Samper, T.G. Trujillo, A. Etxagibel, J. Librero, I. Garmendia, Eduardo Millán |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
biology business.industry Health Policy Public Health Environmental and Occupational Health Angiotensin-converting enzyme medicine.disease Comorbidity Angiotensin II Heart failure Internal medicine biology.protein medicine Cardiology In patient Medical prescription Beta (finance) business Socioeconomic status |
| Zdroj: | Value in Health. 21:S110 |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2018.09.649 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect